ClinConnect ClinConnect Logo
Search / Trial NCT03342781

Using HFNC in Bronchiolitis

Launched by KAYSERI TRAINING AND RESEARCH HOSPITAL · Nov 14, 2017

Trial Information

Current as of August 31, 2025

Completed

Keywords

Bronchiolitis Diffuser Mask High Flow Nasal Oxygen Pediatric Intensive Care Unit

ClinConnect Summary

Acute bronchiolitis results from inflammation of the bronchioles and is usually caused by a viral infection. It is most common in children younger than 2 years old and is one of the most frequent reasons why a child is admitted to hospital. There is no established, specific therapy for acute bronchiolitis and it is commonly treated using supplemental oxygen and by ensuring that the patient remains hydrated.

Oxygen therapy can be applied using a low- or high-flow oxygen delivery system. For example, a diffuser mask (OxyMask) is a low-flow delivery system, which is capable of delivering up t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Included patients were aged between 1 and 24 months and had been diagnosed with moderate or severe acute bronchiolitis. They were admitted to the ICU, requiring supplemental oxygen, because their SpO2 measurements were less than 94% while breathing room air.
  • Exclusion Criteria:
  • Any patients requiring immediate respiratory support (non-invasive or invasive mechanical ventilation, altered mental status, or apnea at presentation), those already admitted to the ICU due to respiratory failure, those with underlying chronic lung disease or cardiovascular disorders, those with obstructions of the upper respiratory tract, and those with cranial malformations were excluded.

About Kayseri Training And Research Hospital

Kayseri Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Kayseri, Turkey, the hospital combines comprehensive patient care with a strong emphasis on education and research, fostering an environment where cutting-edge treatments and therapies can be developed and evaluated. With a commitment to ethical standards and regulatory compliance, Kayseri Training and Research Hospital collaborates with various stakeholders to conduct high-quality clinical studies, contributing to the broader medical community and enhancing the quality of care provided to patients.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials